Connect with us

Diseases & Disorders

Hypoparathyroidism Treatment Market Analysis by Regional Development Status, Market Size, Volume and Value 2018 – 2026

Published

on

Press Release

A recent market study published by XploreMR “Hypoparathyroidism Treatment Market: Global Industry Analysis 2013–2017 & Opportunity Assessment 2018–2026” consists a comprehensive assessment of the most important market dynamics. On conducting a thorough research on the historic as well as current growth parameters of the hypoparathyroidism treatment market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may have a huge impact on the development of the hypoparathyroidism treatment market during the forecast period. It can help the players to modify their manufacturing and marketing strategies to envisage maximum growth in the hypoparathyroidism treatment market in the upcoming years. The report provides detailed information about the current and future growth prospects of the hypoparathyroidism treatment market in the most comprehensive way for the better understanding of readers.

Chapter 1 – Executive Summary

The report commences with the executive summary of the hypoparathyroidism treatment market, which includes the summary of key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the hypoparathyroidism treatment market.

Chapter 2 – Market Overview

Readers can find detailed taxonomy and the definition of the hypoparathyroidism treatment market in this chapter, which will help readers to understand the basic information about the hypoparathyroidism treatment market dynamics, supply chain, cost structure, pricing analysis, list of key distributor and suppliers, list of key market participants included in the report.

Chapter 3 – Global Hypoparathyroidism Treatment Market Analysis (2013–2017) & Opportunity Assessment (2018–2026), By Drug Class

Based on the drug class, the hypoparathyroidism treatment market is segmented into parathyroid hormone, vitamin D analogue and calcium supplements. In this chapter, readers can find information about key trends and developments in the hypoparathyroidism treatment market and market attractive analysis based on the drugs, patches and steroid injectable. In this chapter, readers can find information about key trends and developments in the hypoparathyroidism treatment market and market attractive analysis based on the drug class for each region.

Chapter 4 – Global Hypoparathyroidism Treatment Market Analysis (2013–2017) & Opportunity Assessment (2018–2026), By Route of Administration

Based on the route of administration, the hypoparathyroidism treatment market is segmented into oral, and parenteral. In this chapter, readers can find information about key trends and developments in the hypoparathyroidism treatment market and market attractive analysis based on route of administration for each region.

Get Sample Copy of this report at https://www.xploremr.com/connectus/sample/3407

Chapter 5 – Global Hypoparathyroidism Treatment Market Analysis (2013–2017) & Opportunity Assessment (2018–2026), By Distribution Channels

Based on the distribution channels, the hypoparathyroidism treatment market is segmented into retail pharmacy, hospital pharmacy and online sales. In this chapter, readers can find information about key trends and developments in the hypoparathyroidism treatment market and market attractive analysis based on distribution channels for each region.

Chapter 6 – Global Hypoparathyroidism Treatment Market Analysis (2013–2017) & Opportunity Assessment (2018–2026), By Region

This chapter explains how the hypoparathyroidism treatment market will grow across various geographic regions, such as North America, Latin America, Europe, Asia-Pacific, China and the Middle East & Africa (MEA).

Chapter 7 – North America Hypoparathyroidism Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2026

This chapter includes detailed analysis of the growth of the North America hypoparathyroidism treatment market along with the country-wise assessment including the U.S. and Canada. Readers can also find regional trends, regulations, and market growth based on drug class, route of administration, distribution channel and country of hypoparathyroidism treatment in North America.

Chapter 8 – Latin America Hypoparathyroidism Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2026

Readers can find detailed information about factors such as, pricing analysis, and regional trends that are impacting the growth of the Latin America hypoparathyroidism treatment market. This chapter also includes the growth prospects of the hypoparathyroidism treatment market in leading LATAM countries such as Brazil, Mexico, and Rest of the Latin America.

Chapter 9 – Europe Hypoparathyroidism Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2026

Important growth prospects of the hypoparathyroidism treatment market based on its drug class, route of administration, and distribution channels in several European countries, such as Germany, France, Italy, Spain, the U.K., and Rest of Europe are included in this chapter.

Get Discount on this report at https://www.xploremr.com/connectus/check-discount/3407

Chapter 10 – APEC Hypoparathyroidism Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2026

China, India, Japan, Australia and New Zealand and rest of Asia Pacific are the leading countries in the APEC region that are the prime subject of assessment to obtain growth prospects of the APEC hypoparathyroidism treatment market in this chapter. Readers can find thorough information about the growth parameters of the APEC hypoparathyroidism treatment market during the period 2018–2026.

Chapter 11 – China Hypoparathyroidism Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2026

Readers can find important factors that can have a huge impact on the growth of the hypoparathyroidism treatment market in China based on the market segmentation, during the forecast period. This chapter provides the overview of regulations, drivers, restraints, and trends in the China hypoparathyroidism treatment market.

Chapter 12 – MEA Hypoparathyroidism Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2026

This chapter provides information on how the hypoparathyroidism treatment market will grow in the major countries in MEA region, such as GCC countries, South Africa, and rest of MEA during the period 2018–2026.

Chapter 13 – Competition Landscape, Company Share and Company Profiles

In this chapter, readers can find a comprehensive list of all the leading stakeholders in the hypoparathyroidism treatment market along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments. Market players featured in the report include Shire-NPS Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd, Sun Pharmaceutical Industries Ltd., AbbVie Inc., Teva Pharmaceutical Industries Ltd., and EnteraBio Ltd.

Chapter 14 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 15 – Research Methodology

This chapter helps readers to understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the hypoparathyroidism treatment market.

Buy Full Report at https://www.xploremr.com/cart/3407/SL

This post was originally published on Health News Office

Diseases & Disorders

Current Technological Advancements on Global Arthroscopy Devices Market SWOT Analysis & Technological Innovation by Leading Industry Experts

Published

on

Press Release

Arthroscopy Devices Market Report, published by Allied Market Research, forecasts that the global market was valued at $3,453 million in 2015 and is projected to reach $5,334 million by 2022, growing at a CAGR of 6.2% from 2016 to 2022. The arthroscopic implants segment held nearly two-fifths of the total market in 2015.

Arthroscopy is a minimally invasive surgical procedure that helps surgeons examine and treat bone and joint related problems using an arthroscope and other arthroscopy devices (such as visualization systems, arthroscopic implants, power shaver systems, radiofrequency devices, and others). They are essential to diagnose and treat osteoarthritis, rheumatoid arthritis, carpal tunnel syndrome, bone tumor, and others. The market for arthroscopy devices has grown tremendously in the recent years due to increase in number of sport injuries, rapid ageing population and increase in patient preference for minimally invasive surgeries.

Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/426

Key factors that boost the growth of global arthroscopy devices market are the benefits of arthroscopy devices including shorter recovery time, minimal post-operative complications, and greater precision to perform surgeries of highly sensitive areas such as spine. In addition, upsurge in obesity rate causing bone degradation in population and the rise in demand for arthroscopic treatment in emerging economies offer lucrative opportunities for the growth of this market. However, dearth of skilled professionals and high costs associated with arthroscopic devices especially the novel implants (biodegradable and 3D implants) impede the market growth.

Arthroscopic implants are anticipated to dominate the arthroscopy devices market throughout the analysis period accounting for over two-fifths of the total share in 2015. This is owing to the rapid adoption attributed by the fact that implants mimic real joint-movement and are imperative in supporting damaged bone by facilitating faster joint recovery.

Visualization systems segment is expected to be the fastest growing sector of the market owing to the incorporation of advanced technologies in visualization systems, for instance, arthroscopic cameras embedded with ultra-high definition and 4-light emitting diode (LED) multi-light technology, which enhances the video quality. The global visualization system market is expected to grow at a CAGR of 8.2% from 2016 to 2022.

Spine arthroscopy dominated the application segment with about two-sevenths share in 2015 growing at a CAGR of 6.2% from 2016 to 2022. Growth in number of spine ailments such as degenerative conditions of the spine, spine trauma, tumors, spinal deformity, and infection of the spine amongst all age groups drives the market growth.

30% Discount on Purchase @ https://www.alliedmarketresearch.com/purchase-enquiry/426

Key findings of the Arthroscopy Devices Market:

  • The knee arthroscopy market is anticipated to witness the fastest growth rate during 20162022.
  • Visualization systems is projected to be the fastest growing segment during the analysis period.
  • Knee implants dominated the arthroscopic implants market, and is expected to grow at a CAGR of 5.2% during the forecast period.
  • North America dominated global arthroscopy devices market and is projected to grow at a CAGR of 5.4%.
  • Spine arthroscopy application occupied nearly two-sevenths of the total market in 2015.
  • India is the fastest growing country in Asia-Pacific region, registering a CAGR of 9.0% from 2016 to 2022.

In 2015, Asia-Pacific and LAMEA collectively accounted for one-fourth share of the total arthroscopy devices market and this trend is expected to continue due to rise in geriatric population & targeted diseases, specifically in China and India with large and other developing economies of the regions. Rise in sports as a career, surge in disposable income, improvement in healthcare funding, and high populace demanding more arthroscopic procedures fuel the growth of the arthroscopy devices market in the Asia-Pacific region.

The major companies profiled in the report include Arthrex, Inc. Conmed Corporation, Johnson & Johnson, KARL STORZ GmbH & Co. KG, Medtronic, Plc, Richard Wolf GmbH, Smith & Nephew, Plc, Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings, Inc.

Related Reports:

Americas Clinical Chemistry Analyzer Market – Opportunities and Forecasts, 2019-2026

Pyrogen Testing Market – Opportunities and Forecast, 2019-2026

This post was originally published on Health News Office

Continue Reading

Diseases & Disorders

Dental Consumables Market is expected to reach $55,584 million by 2023

Published

on

Press Release

Dental Consumables Market  The report provides detailed analyses of the top winning strategies, market share & estimations, driving factors & opportunities, key market segments, and competitive landscape. As per the report, the global dental consumables market was pegged at $41.06 billion in 2017 and is expected to garner $55.58 billion by 2023, growing at a CAGR of 5.2% through 2023.

High prevalence of dental diseases among geriatric population, surge in dental tourism across emerging economies, and increase in demand for minimally invasive dental procedures drive the growth of the global dental consumables market. Moreover, increase in awareness about oral hygiene supplements the market growth. However, high cost of dental products along with very limited reimbursement hampers the growth of the market. On the contrary, rise in demand for dental cosmetic procedures and increase in awareness about proper dentition are expected to provide lucrative opportunities for the market players in the near future.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/442

Retail dental care essentials segment to retain largest share through 2023

The retail dental care essentials segment held the largest share in 2017, contributing nearly two-thirds of the total market revenue. This is attributed to the surge in awareness programs for oral health & hygiene launched by major players & government organizations. However, the periodontics segment is projected to register the fastest CAGR of 12.2% during the forecast period, owing to rapid development of novel technologies and rise in incidence of periodontal diseases. The other segments analyzed in the report include dental implants, dental prosthetics, endodontics, and orthodontics.

Asia-Pacific region to manifest fastest growth by 2023

Asia-Pacific region is estimated to register the fastest CAGR of 7.6% through 2023, owing to rise in awareness regarding dental disorders, surge in geriatric population, improved accessibility to medical services, and increase in product availability. However, Europe held the largest market share in 2017, contributing more than one-third of the total revenue, owing to increase in the number of dental restoration cases due to high incidence of dental disorders in the region. The other regions analyzed in the report include North America and Latin AmericaMiddle East and Africa (LAMEA).

30% Discount on Purchase: https://www.alliedmarketresearch.com/purchase-enquiry/442

Torchbearers of the market

The major market players analyzed in the report include 3M Company, Danaher Corporation, Institut Straumann AG, Koninklijke Philips N.V., Procter & Gamble, Colgate-Palmolive Company, Dentsply Sirona Inc., Ivoclar Vivadent, OSSTEM IMPLANT Co., Ltd., and Zimmer Biomet Holdings, Inc.

Related Reports:

Asia Pacific Computerized Physician Order Entry Market – Opportunities and Forecasts, 2019-2026

Protein Purification and Isolation Market – Opportunities and Forecasts, 2019-2026

This post was originally published on Health News Office

Continue Reading

Diseases & Disorders

Pharmacy Automation Systems Market Outlook, Size, Trends & Sales in 2019 Reports

Published

on

Press Release

Pharmacy Automation Systems Market Report, published by Allied Market Research, forecasts that the global market was valued at $3,312 million in 2015, and is projected to reach $5,602 million by 2022, growing at a CAGR of 7.8% from 2016 to 2022.The automated medication dispensing systems held over half of the share of the global market in 2015.

Pharmacy automation systems manage dispensing, storing, filling, capping, and labeling of medications and securely store patients data. Constant technological developments, long-term cost savings associated with these systems, growth in adoption in emerging nations, rise in need to reduce medication errors, and increase in medical tourism in developing countries drive the growth of the market. However, high capital investment is projected to restrain the market growth during the forecast period.

Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/484

Detailed segmentation of the global pharmacy automation systems market is provided in terms of product type, end user, and geography. Based on product type, the market is divided into automated medication dispensing systems, automated storage & retrieval systems, automated packaging & labeling systems, tabletop tablet counters, and automated compounding devices. The automated medication dispensing segment held the largest share of 49.0% in 2015, owing to high these machines due to their point-of-care availability, capability to control storage & distribution, and maintain record of medicines. By end user, the market is categorized into retail pharmacy, hospital pharmacy, and others (long-term care pharmacy, clinic pharmacy, and mail order pharmacy). Pharmacy automation systems held over half of the share in 2015 owing to major use in hospitals to package, dispense, and label medicines, and are expected to continue this trend in the future.

Key Findings of the Pharmacy Automation Systems Market:

Automated medication dispensing systems was the leading segment in 2015. North America is projected to grow at a CAGR of 7.5% from 2016 to 2022.Asia-Pacific is expected to grow at the highest CAGR. China is expected to grow at the highest CAGR in the Asia-Pacific pharmacy automation systems market. France is expected to grow with the highest growth rate during the analysis period among the European countries. Hospital held the largest market share o in 2015.

Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America generated the highest revenue, accounting for over half of the market share in 2015, owing to rise in expenditure to upgrade healthcare systems and high demand for technologically advanced devices for rapid & accurate distribution of medicines.

However, Asia-Pacific is projected to grow at the highest CAGR during the analysis period, owing to rise in healthcare expenditure, increase in per capita income, and improvement in healthcare infrastructure.

30% Discount on Purchase @ https://www.alliedmarketresearch.com/purchase-enquiry/484

The report provides a comprehensive analysis the key players operating in this market, including Baxter International Inc.; Becton, Dickinson and Company; Cerner Corporation; Capsa Healthcare; McKesson Corporation; Omnicell Inc.; ScriptPro LLC; Swisslog Holdings AG; Talyst, Inc.; and Yuyama Co., Ltd.

Related Reports:

Microbial Identification Market – Opportunities and Forecasts, 2019-2026

North America Ophthalmology Cataract Surgery Devices Market – Opportunities and Forecasts, 2019-2026

This post was originally published on Health News Office

Continue Reading

Trending